IRAK

Phase 1b Study of R289 in Patients with Lower-risk Myelodysplastic Syndromes (LR MDS)

Near Add Your Location

Sorting 13 by

MDS Center of Excellence

  • Accepting patients

MDS Center of Excellence

  • Accepting patients

MDS Center of Excellence

  • Accepting patients

MDS Center of Excellence

Chao Family Comprehensive Cancer Center
University of California, Irvine
Orange, CA
  • Accepting patients

MDS Center of Excellence

  • Accepting patients

MDS Center of Excellence

  • Accepting patients

MDS Center of Excellence

Ohio State University Comprehensive Cancer Center
James Cancer Hospital and Solove Research Institute
Columbus, OH
  • Not yet accepting

MDS Center of Excellence

MDS Center of Excellence

Duke Cancer Center
Duke University Medical Center
Durham, NC
  • Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.